nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

10.04.2023 | Original Article

Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis

verfasst von: Yang Long, Yuxi Zhang

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

To assess clinical efficacy and safety of liraglutide combined with metformin (LMT) in obese patients with type 2 diabetes (ODP) by conducting a meta-analysis of randomized controlled trials (RCTs).

Methods

PubMed, EMBASE, Cochrane Library, CNKI, CNKI, and VIP databases were systematically searched for randomized controlled trials (RCTs) through January 1, 2015 to investigate the effectiveness of liraglutide combined with metformin treatment (LMT) in obesity patients with type 2 diabetes (ODP). Meta-analysis (using generic inverse variance random effects model) was performed when there were two or more studies reporting on the same evaluation indicators. Review Manager V.5.3 was used to perform the meta-analysis.

Results

A total of 1289 participants from 15 RCTs were selected for the final meta-analysis. A synthesis of current evidence of LMT for treating ODP was provided in this protocol.

Conclusion

This review will offer insights for future research and provide reference for LMT treatment for ODP.

Jiang T, Zhang N, Zuo X, et al. (2017) Effects of exenatide on dietary habits in obese type 2 diabetic patients. Chin J Diabetes Mellitus 9:87–40

Ji L, Liu J, Yang J, et al. (2019) Comparison of efficacy and safety of metformin XR to IR in the treatment of type 2 diabetes in north and south China. Chin J Diabetes Mellitus 27:369–374

Xiao Q, Liu H (2018) Long term clinical and economic outcomes associated with I liraglutide versus sitagliptin in the treatment of type 2 diabetes. Chin Hosp Pharm J 38:1207–1211+1235. https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2018.11.17

Cao L, Song X, Feng K, et al. (2019) Effects of liraglutide intervention combined with PCI therapy on ventricular remodeling and cardiac function in patients with acute myocardial infarction and type 2 diabetes mellitus [J]. Chin J Endocrinol Metab Chin J Endocrinol Metab 35:121–127

HuanXiong WuX, Guo X, et al. (2019) Practice of medication therapy management for a patient with obesity diabetes mellitus by clinical pharmacists. China Pharmacy 26:1830–1834

D M, A L, J T, DG A, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRef

Liu Z, Feng Q, Li L (2019) To explore the efficacy of Liraglutide combined with metformin in the treatment of type 2 diabetes mellitus with obesity (T2DM) patients. Straits Pharmacy 31:223–224

Zhao X, Wang Q (2021) Clinical observation of lilalutide combined with metformin in the treatment of obese patients with newly diagnosed type 2 diabetes mellitus. China Pharmaceuticals 30:72–74

Tian X (2021) Clinical observation of metformin combined with liraglutide in the treatment of obesity type 2 diabetes mellitus Smart Healthcare 7:96–98. https://doi.org/10.19335/j.cnki.2096-1219.2021.10.032

10.

Song W (2016) Observation of clinical effoct of liraghutide combined with metformin in the treatment of patients with obesity type 2 diabetes. Drugs and Clinic 13:23–26

11.

Li W, Zhang Q, Yuan N, Chen H (2015) Clinical observation on liraglutide in treating early-onset T2DM of obstructive sleep apnea hypopnea syndrome complicating obesity. China Pharmaceuticals 24:58–60

12.

Chen R (2022) Effect of liraglutide combined with metformin in the treatment of obese patients with type 2 diabetes mellitus. Chin J Mod Drug Appl 16:31–34. https://doi.org/10.14164/j.cnki.cn11-5581/r.2022.12.008

13.

Chen L (2016) Clinical curative effect of liraglutide combined with metformin in the treatment of obese patients with type 2 diabetes. Chinese Community Doctors 32:37+39

14.

Guo J (2018) Pharmacological characteristics and clinical application of Liraglutide in the treatment of obese type 2 diabetes mellitus Northern Chinese Pharmacy 15:75–75

15.

wang J, Lu Y, Wang H, Yang Y, (2021) Effects of liraglutide on fasting blood glucose, 2h postpranital blood glucose and glycosylated hemoglobin in patiengs with obese type2 diabetes mellitus. Hebei Medical Journal 43:897–900

16.

Su J (2018) Clinical observation on the treatment of liraglutide combined with metformin in patients with type 2 diabetes with obesity. Journal of Practical Medical Techniques 25:816–819. https://doi.org/10.19522/j.cnki.1671-5098.2018.08.002

17.

Zheng H (2020) Pharmacological characteristics and clinical effects of Liraglutide in the treatment of obese type 2 diabetes mellitus Northern Pharmacy 17:121–122

18.

Huang H (2019) Efficacy of Liraglutide in the treatment of obese patients with type 2 diabetes. Journal of Heze Medical College 31:14–15+22

19.

Luo G, Liu J (2015) Efficacy of liraglutide combined with metformin in the treatment of newly diagnosed obese type 2 diabetes mellitus. Contemporary Medicine 21:121–122

20.

Yang D (2017) Clinical observation of liraglutide combined with metformin in the treatment of obese type 2 diabetes mellitus. Henan Medical Research 26:4475–4476

21.

Lin B, He M, Wang J (2020) Clinical observation of liraglutide combined with metformin in the treatment of newly diagnosed obese type 2 diabetes China Medicine and Pharmacy 10:78–81

22.

MO B, EM B, CT B, TVS D, PM H, CK R, KD R, AS K (2021) Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: post hoc analysis of the ellipse trial. Pediatr Obes 16:e12778. https://doi.org/10.1111/ijpo.12778. Epub 2021 Feb 25. PMID: 33634589; PMCID: PMC8277686

23.

WT G, AL B, D D, G M, SD P, A S, D S, D S, C J, O M (2020) Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized controlled trial. Diabetes Care 43:1085–1093. https://doi.org/10.2337/dc19-1745

24.

Qiu H, Kong L, Ma L (2019) Clinical efficacy and safety evaluation of metformin combined with liraglutide in the treatment of obese type 2 diabetes. China Modern Doctor 57:98–101

25.

Huang H, Lai D, Zhou L, et al. (2020) Clinical efficacy of Liraglutide, lipliptin and metformin in the treatment of type 2 diabetes mellitus with non-alcoholic fatty liver disease. Chinese Modern Pharmaceutical Application 14:157–159

26.

Yan Y (2019) To observe the clinical effect of liraglutide combined with metformin in the treatment of type 2 diabetes. Chinese Journal of Modern Pharmaceutical Application 13:197–198

27.

Lao H (2021) Analysis of the efficacy and metabolic index of liraglutide combined with metformin in the treatment of obese type 2 diabetes. Diabetes New World 24(92–94):98

28.

Gong L (2021) Clinical efficacy of Liraglutide combined with metformin in the treatment of overweight/obese type 2 diabetes mellitus. Chin J of Clinical Rational Drug Use 14:68–70

29.

qingren N, Luo Q, (2021) Analysis the efficient of liraglutide combined with metformin in the treatment of obese Type 2 diabetes patients in plateau area. Qinghai Medical Journal 51:12–14

30.

Wu Y, Liu J, Yang Y (2021) Comparative study on dulaglutide and liraglutide combined with metformin in treatment of overweight and obesity type 2 diabetes mellitus. Drugs & Clinic 36:957–960

Titel: Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis
verfasst von: Yang Long
Yuxi Zhang
Publikationsdatum: 10.04.2023
Verlag: Springer International Publishing
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 6/2023
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-023-03337-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

The impact of a novel surgical forum, ‘Virtual Surgical Speed Dating’, on career perception for medical students: a pilot study

Efficacy of topical insulin for recurrent epithelial corneal erosions

Drug-free remission is an achievable target with immunosuppressive treatment in idiopathic granulomatous mastitis

Acute liver failure secondary to the use of unmonitored drugs and herbal supplements: an underreported and serious issue

Motives behind low-acuity geriatric emergency medicine attenders: a picture from free healthcare system